Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene
very early signs of prostate cancer :: Article Creator Researchers Question The Use Of "cancer" For Certain Prostate Conditions A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients may benefit if doctors stop calling certain early-stage changes to the prostate "cancer" at all. Prostate cancer is the second leading cause of cancer death worldwide in men, but far more patients are diagnosed than die of the disease. In 2022, there were nearly 1.5 million cases of prostate cancer, but only 400,000 deaths. Low-grade prostate cancer, commonly known as GG1 among physicians, virtually never metastasizes or causes symptoms. Some medical researchers have wondered recently if it would be a benefit to public health to call GG1 something other than cancer. To further this discussion, researchers convened an international symposium with participants from multiple fie...